Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma

Figure 1 Survival per disease stage is similar for duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. Survival specified for duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. A: Stage I-II (P = 0.841); B: Stage III (P = 0.927); C: Stage IV (P = 0.676). Kaplan-Meier curves are shown. No. at risk: Number at risk.

Figure 2 Overall survival for patients with stage IV duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma compared based on treatment modality. A: Overall survival of patients treated with local therapy of metastases compared with systemic therapy or supportive care (all stage IV patients were included); B: Subgroup analysis of patients with liver metastases eligible for local treatment only. Kaplan-Meier curves are shown per treatment group. LT: Local treatment of metastases; ST: Systemic therapy; SC: Supportive care; No. at risk: Number at risk.